These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 25659373)
1. Suppressive effects of gemcitabine plus cisplatin chemotherapy on regulatory T cells in nonsmall-cell lung cancer. Chen C; Chen Z; Chen D; Zhang B; Wang Z; Le H J Int Med Res; 2015 Apr; 43(2):180-7. PubMed ID: 25659373 [TBL] [Abstract][Full Text] [Related]
2. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery. Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703 [TBL] [Abstract][Full Text] [Related]
3. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients. Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592 [TBL] [Abstract][Full Text] [Related]
4. Elevated Circulating CD4 Hu X; Gu Y; Zhao S; Hua S; Jiang Y Cancer Biother Radiopharm; 2019 Jun; 34(5):325-333. PubMed ID: 30925076 [No Abstract] [Full Text] [Related]
5. Modified spatial architecture of regulatory T cells after neoadjuvant chemotherapy in non-small cell lung cancer patients. Cai S; Zhao M; Yang G; Li C; Hu M; Yang L; Xing L; Sun X Int Immunopharmacol; 2024 Aug; 137():112434. PubMed ID: 38889507 [TBL] [Abstract][Full Text] [Related]
6. CD4+CD25+CD127-Foxp3+ and CD8+CD28- Tregs in Renal Transplant Recipients: Phenotypic Patterns, Association With Immunosuppressive Drugs, and Interaction With Effector CD8+ T Cells and CD19+IL-10+ Bregs. Aly MG; Ibrahim EH; Karakizlis H; Weimer R; Opelz G; Morath C; Zeier M; Ekpoom N; Daniel V Front Immunol; 2021; 12():716559. PubMed ID: 34335631 [TBL] [Abstract][Full Text] [Related]
7. Changes of Lymphocyte Subgroups in Non-Small Cell Lung Cancer Patients Before and During Chemotherapy. Wang Q; Yang L; Xu F; Wang J; An G; Ma Y Clin Lab; 2015; 61(10):1343-51. PubMed ID: 26642694 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients. Pircher A; Gamerith G; Amann A; Reinold S; Popper H; Gächter A; Pall G; Wöll E; Jamnig H; Gastl G; Wolf AM; Hilbe W; Wolf D Lung Cancer; 2014 Jul; 85(1):81-7. PubMed ID: 24780112 [TBL] [Abstract][Full Text] [Related]
10. Circulating regulatory T cell subsets predict overall survival of patients with unresectable pancreatic cancer. Liu C; Cheng H; Luo G; Lu Y; Jin K; Guo M; Ni Q; Yu X Int J Oncol; 2017 Aug; 51(2):686-694. PubMed ID: 28714519 [TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory Effect of Lentinan on Aberrant T Subsets and Cytokines Profile in Non-small Cell Lung Cancer Patients. Wang XE; Wang YH; Zhou Q; Peng M; Zhang J; Chen M; Ma LJ; Xie GM Pathol Oncol Res; 2020 Jan; 26(1):499-505. PubMed ID: 30460541 [TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma. Ganesan AP; Johansson M; Ruffell B; Yagui-Beltrán A; Lau J; Jablons DM; Coussens LM J Immunol; 2013 Aug; 191(4):2009-17. PubMed ID: 23851682 [TBL] [Abstract][Full Text] [Related]
13. Critical stoichiometric ratio of CD4(+) CD25(+) FoxP3(+) regulatory T cells and CD4(+) CD25(-) responder T cells influence immunosuppression in patients with B-cell acute lymphoblastic leukaemia. Bhattacharya K; Chandra S; Mandal C Immunology; 2014 May; 142(1):124-39. PubMed ID: 24354800 [TBL] [Abstract][Full Text] [Related]
14. A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinoma. Ricci S; Antonuzzo A; Galli L; Tibaldi C; Bertuccelli M; Lopes Pegna A; Petruzzelli S; Bonifazi V; Orlandini C; Franco Conte P Cancer; 2000 Oct; 89(8):1714-9. PubMed ID: 11042565 [TBL] [Abstract][Full Text] [Related]
15. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression]. Chen YL; Chen XR; Qin LX; Yang YF; Tang YM Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy. Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel, cisplatin, and gemcitabine combination chemotherapy within a multidisciplinary therapeutic approach in metastatic nonsmall cell lung carcinoma. Rodriguez J; Cortes J; Calvo E; Azinovic I; Fernandez-Hildago O; Martinez-Monge R; Garzon C; de Irala J; Martinez-Aguillo M; Ramon Y Cajal T; Brugarolas A Cancer; 2000 Dec; 89(12):2622-9. PubMed ID: 11135224 [TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of gemcitabine alone and in combination with cisplatin in the treatment of nonsmall cell lung cancer. Lees M; Aristides M; Maniadakis N; McKendrick J; Botwood N; Stephenson D Pharmacoeconomics; 2002; 20(5):325-37. PubMed ID: 11994042 [TBL] [Abstract][Full Text] [Related]
19. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice. Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069 [TBL] [Abstract][Full Text] [Related]
20. Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Leong PP; Mohammad R; Ibrahim N; Ithnin H; Abdullah M; Davis WC; Seow HF Immunol Lett; 2006 Feb; 102(2):229-36. PubMed ID: 16246429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]